CING

Cingulate Inc.

There isn't enough reported data to score CING yet.

CING Fundamentals

MetricStatus
Unavailable
Under pressure
Unavailable
Unavailable

CING's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.

CING PE Valuation

CING has no meaningful PE right now: it lost money over the past year.

CING Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
--
Limited
Low

Analysts expect CING's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

CING Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $4.49 on Nov 12.

There is not enough scenario data to assess CING's risk to reward.

CING Earnings Per Share

Q3 2023: $-390.52Q4 2024: $-16.80Q1 2025: $-10.64Q2 2025: $-6.26Q3 2025: $-5.78Q4 2025: $-4.44Q1 2026: $-4.35Q2 2026: $-3.71
Q3 2023: $-390.52Q4 2024: $-16.80Q1 2025: $-10.64Q2 2025: $-6.26Q3 2025: $-5.78Q4 2025: $-4.44Q1 2026: $-4.35Q2 2026: $-3.71
QuarterTTM EPSYoY
Q2 2026-$3.71+$2.55
Q1 2026-$4.35+$6.29
Q4 2025-$4.44+$12.36

CING is still losing money, but far less than before: $3.71 per share over the past year, against $404.92 at its worst in mid-2023.

CING Quarterly Revenue

Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --
Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --

CING's revenue is shrinking: $0 last quarter.

CING Free Cash Flow

Q3 2023: −$4MQ4 2023: −$3MQ1 2024: −$9MQ2 2024: −$2MQ3 2024: −$4MQ4 2024: −$4MQ1 2025: --Q2 2025: --Q3 2025: −$4MQ4 2025: −$4MQ1 2026: −$7MQ2 2026: −$6M
Q3 2023: −$4MQ4 2023: −$3MQ1 2024: −$9MQ2 2024: −$2MQ3 2024: −$4MQ4 2024: −$4MQ1 2025: --Q2 2025: --Q3 2025: −$4MQ4 2025: −$4MQ1 2026: −$7MQ2 2026: −$6M
QuarterFree cash flowYoY
Q4 2025-$3.8M+$524.5K
Q3 2025-$4.2M-$501.7K
Q4 2024-$4.3M-$1.5M
Q3 2024-$3.7M+$549.3K
Q2 2024-$1.8M+$2.8M
Q1 2024-$8.8M-$5.2M
Q4 2023-$2.7M+$1.6M
Q3 2023-$4.3M-$892.3K

CING has burned cash in almost every quarter: −$21M over the past year, against −$19M the year before.

CING Total Shares

Q3 2023: 82,361Q1 2024: 412,126Q2 2024: 586,313Q3 2024: 2MQ1 2025: 4MQ2 2025: 4MQ3 2025: 5MQ1 2026: 10MQ2 2026: 13M
Q3 2023: 82,361Q1 2024: 412,126Q2 2024: 586,313Q3 2024: 2MQ1 2025: 4MQ2 2025: 4MQ3 2025: 5MQ1 2026: 10MQ2 2026: 13M
PeriodChange %Net change
Quarterly+35%+3.4M shares
1 year+262%+9.5M shares
3 years+27882%+13.1M shares

CING has 13M diluted shares, up 262% from a year ago.

CING Net Leverage

CING's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

CING Weekly Momentum

MetricValueStatus
RSI45.0Neutral
Stochastic25.1Neutral

CING's weekly RSI is 45 (neutral) and its Stochastic is 25 (neutral).

CING PE vs Healthcare Sector

CING has no meaningful PE right now: it lost money over the past year.

CING Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$4.694.3% below
20 week MA$4.928.7% below
50 week MA$5.2214% below
100 week MA$4.704.5% below
200 week MA$52.091% below

CING is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.

CING Yearly ROI

YearStart priceEnd priceROI
2021$883.2$612.0-31%
2022$612.0$229.3-63%
2023$229.3$91.8-60%
2024$91.8$4.78-95%
2025$4.78$4.18-13%
2026 YTD$4.18$4.49+7.4%

CING has finished every year since 2021 lower, and it's up 7.4% so far in 2026.

Give your agent the market.

Get API key